97 related articles for article (PubMed ID: 19524002)
1. Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.
Kéri S; Seres I; Kelemen O; Benedek G
Neurochem Int; 2009 Dec; 55(7):606-9. PubMed ID: 19524002
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 1-induced AKT phosphorylation in monozygotic twins discordant for schizophrenia.
Seres I; Kelemen O; Benedek G; Kéri S
Neurochem Int; 2010 Jul; 56(8):906-10. PubMed ID: 20371257
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal volume and the AKT signaling system in first-episode schizophrenia.
Szamosi A; Kelemen O; Kéri S
J Psychiatr Res; 2012 Mar; 46(3):279-84. PubMed ID: 22209534
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. [The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia].
Juhász LZ; Kemény K; Linka E; Sántha J; Bartkó G
Ideggyogy Sz; 2003 Sep; 56(9-10):303-8. PubMed ID: 14608951
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia.
Kéri S; Beniczky S; Kelemen O
Am J Psychiatry; 2010 Apr; 167(4):444-50. PubMed ID: 20048019
[TBL] [Abstract][Full Text] [Related]
7. Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: relationship to premorbid abilities and symptom improvement.
Bayless JD; McCormick LM; Brumm MC; Espe-Pfeifer PB; Long JJ; Lewis JL
J ECT; 2010 Mar; 26(1):47-52. PubMed ID: 19710624
[TBL] [Abstract][Full Text] [Related]
8. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
[TBL] [Abstract][Full Text] [Related]
9. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
Jabben N; Arts B; Krabbendam L; van Os J
Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
[TBL] [Abstract][Full Text] [Related]
10. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
12. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
13. delta opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells.
Shahabi NA; McAllen K; Sharp BM
J Pharmacol Exp Ther; 2006 Feb; 316(2):933-9. PubMed ID: 16249373
[TBL] [Abstract][Full Text] [Related]
14. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
15. Clinical validity of the Repeatable Battery for the Assessment of Neuropsychological Status among patients with schizophrenia in the Republic of Armenia.
Azizian A; Yeghiyan M; Ishkhanyan B; Manukyan Y; Khandanyan L
Arch Clin Neuropsychol; 2011 Mar; 26(2):89-97. PubMed ID: 21177761
[TBL] [Abstract][Full Text] [Related]
16. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
Kaneda Y; Jayathilak K; Meltzer HY
Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
18. Akt activation is necessary for growth factor-induced trafficking of functional K(Ca) channels in developing parasympathetic neurons.
Chae KS; Martin-Caraballo M; Anderson M; Dryer SE
J Neurophysiol; 2005 Mar; 93(3):1174-82. PubMed ID: 15509648
[TBL] [Abstract][Full Text] [Related]
19. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
20. Theory of mind and perceptual context-processing in schizophrenia.
Uhlhaas PJ; Phillips WA; Schenkel LS; Silverstein SM
Cogn Neuropsychiatry; 2006 Jul; 11(4):416-36. PubMed ID: 17354079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
